Stocklytics Platform
Asset logo for symbol SNGX
Soligenix
SNGX74
$3.61arrow_drop_up0.02%$0.00
High Growth
Penny Stock
Asset logo for symbol SNGX
SNGX74

$3.61

arrow_drop_up0.02%

Performance History

Chart placeholder
Key Stats
Open$3.59
Prev. Close$3.61
EPS-8.00
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$8.23M
PE Ratio-
LOWHIGH
Day Range3.50
3.64
52 Week Range0.32
14.83
Ratios
Revenue-
EBITDA Margin %-
EPS-8.00

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Soligenix (SNGX)

Soligenix Inc (SNGX) is a biopharmaceutical company focused on developing and commercializing novel treatments for rare diseases. With a market cap of X, the company is dedicated to improving the lives of patients through its innovative therapies.
SNGX stock has shown a volatile price history, with fluctuations in response to various market conditions and news events. Investors should carefully analyze the stock's performance and consider factors such as the company's financials, pipeline, and industry trends before making any investment decisions.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Christopher J. Schaber Ph.D.
Headquarters
Princeton
Employees
13
Exchange
NASDAQ
add Soligenix  to watchlist

Keep an eye on Soligenix

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the market capitalization of Soligenix (SNGX)?

Soligenix (SNGX) has a market capitalization of $8.23M. The average daily trading volume is 88.7K, indicating the stock's liquidity and investor engagement.
help

What is Soligenix 's (SNGX) price per share?

The current price per share for Soligenix (SNGX) is $3.6. The stock has seen a price change of -$0.01 recently, indicating a -0.33% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Soligenix (SNGX)?

For Soligenix (SNGX), the 52-week high is $14.83, which is 312.17% from the current price. The 52-week low is $0.32, the current price is 1.02K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Soligenix (SNGX) a growth stock?

Soligenix (SNGX) has shown an average price growth of 0.41% over the past three years. It has received a score of -3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Soligenix as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Soligenix (SNGX) stock price performance year to date (YTD)?

As of the latest data, Soligenix (SNGX) has a year-to-date price change of -73.54%. Over the past month, the stock has experienced a price change of 7.72%. Over the last three months, the change has been -5.81%. Over the past six months, the figure is -63.73%. Looking at a longer horizon, the five-year price change stands at -98.32%.
help

Is Soligenix (SNGX) a profitable company?

Soligenix (SNGX) has a net income of -$6.14M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 10.81% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -74.5K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $90.76K. Operating income is noted at -$8.54M. Furthermore, the EBITDA is -$7.77M.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media